Business
NEU: Double-digit profit growth, strong segment results, and strategic investment mark a robust quarter
NEU: Double-digit profit growth, strong segment results, and strategic investment mark a robust quarter
About this update from Neuca S.a.
Sales and profits grew solidly in 3Q and 1-3Q 2024, with strong performance in patient and clinical trial segments, improved margins, and continued leadership in customer satisfaction. Viking Global's investment in Humaneva and robust dividend payouts highlight strategic progress.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.